Veterans, lawmakers, and PTSD experts gathered to advocate for FDA approval of MDMA-assisted therapy and highlight the impact of PTSD and veteran suicide in U.S. on July 10 in Washington D.C. The FDA is expected to decide this week whether to approve the drug.
This article was originally published on August 01, 2024.